pimobendan has been researched along with Kidney Failure, Chronic in 1 studies
pimobendan: produces arterial & venous dilatation in dogs; structure given in first source
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Przechera, M | 1 |
| Roth, W | 1 |
| Kühlkamp, V | 1 |
| Risler, T | 1 |
| Haehl, M | 1 |
1 other study available for pimobendan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Pharmacokinetic profile and tolerability of pimobendan in patients with terminal renal insufficiency.
Topics: Adult; Blood Pressure; Cardiotonic Agents; Drug Tolerance; Female; Heart Rate; Humans; Kidney Failur | 1991 |